127 related articles for article (PubMed ID: 8738730)
1. Defective aggregation in cirrhosis is independent of in vivo platelet activation.
Laffi G; Cinotti S; Filimberti E; Ciabattoni G; Caporale R; Marra F; Melani L; Grossi A; Carloni V; Gentilini P
J Hepatol; 1996 Apr; 24(4):436-43. PubMed ID: 8738730
[TBL] [Abstract][Full Text] [Related]
2. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
6. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
7. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G
Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790
[TBL] [Abstract][Full Text] [Related]
9. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
[TBL] [Abstract][Full Text] [Related]
10. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella F; Healy D; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463
[TBL] [Abstract][Full Text] [Related]
11. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites.
Eldor A; Lellouche F; Goldfarb A; Rachmilewitz EA; Maclouf J
Blood; 1991 Apr; 77(8):1749-53. PubMed ID: 2015401
[TBL] [Abstract][Full Text] [Related]
12. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
Forastiero R; Martinuzzo M; Carreras LO; Maclouf J
Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet reactivity in Klinefelter men: something new to consider.
Di Minno MN; Esposito D; Di Minno A; Accardo G; Lupoli G; Cittadini A; Giugliano D; Pasquali D
Andrology; 2015 Sep; 3(5):876-81. PubMed ID: 26216452
[TBL] [Abstract][Full Text] [Related]
15. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome.
Tönshoff B; Momper R; Kühl PG; Schweer H; Schärer K; Seyberth HW
Kidney Int; 1990 Apr; 37(4):1134-41. PubMed ID: 2111418
[TBL] [Abstract][Full Text] [Related]
16. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2.
Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J; Sawada M
Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):47-51. PubMed ID: 2339136
[TBL] [Abstract][Full Text] [Related]
17. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
18. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction.
Uyama O; Shimizu S; Nakanishi T; Nakahama H; Takiguchi A; Hayashi Y; Yamamoto S; Sugita M
Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173
[TBL] [Abstract][Full Text] [Related]
19. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
